A population-based validation study of the DCIS Score predicting recurrence risk in individuals treated by breast-conserving surgery alone

Validated biomarkers are needed to improve risk assessment and treatment decision-making for women with ductal carcinoma in situ (DCIS) of the breast. The Oncotype DX(®) DCIS Score (DS) was shown to predict the risk of local recurrence (LR) in individuals with low-risk DCIS treated by breast-conserv...

詳細記述

保存先:
書誌詳細
出版年:Breast Cancer Res Treat
主要な著者: Rakovitch, Eileen, Nofech-Mozes, Sharon, Hanna, Wedad, Baehner, Frederick L., Saskin, Refik, Butler, Steven M., Tuck, Alan, Sengupta, Sandip, Elavathil, Leela, Jani, Prashant A., Bonin, Michel, Chang, Martin C., Robertson, Susan J., Slodkowska, Elzbieta, Fong, Cindy, Anderson, Joseph M., Jamshidian, Farid, Miller, Dave P., Cherbavaz, Diana B., Shak, Steven, Paszat, Lawrence
フォーマット: Artigo
言語:Inglês
出版事項: Springer US 2015
主題:
Clinical Trial
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4491104/
https://ncbi.nlm.nih.gov/pubmed/26119102
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10549-015-3464-6
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料